Subscribe: Market Wire - Medical and Healthcare: Dentistry
Preview: Market Wire - Medical and Healthcare: Dentistry

Marketwired - Dentistry

Marketwired - Dentistry

Last Build Date: Mon, 27 Feb 2017 09:07:01 EST

Copyright: Copyright: (C) Marketwired

Amedica Announces Results of Independent Femoral Head Wear Testing

Mon, 27 Feb 2017 09:00:00 EST

SALT LAKE CITY, UT--(Marketwired - Feb 27, 2017) - Amedica Corporation (NASDAQ: AMDA), an innovative biomaterial company which develops and manufactures silicon nitride as a platform for biomedical applications, announced today that Researchers from the Department of Orthopaedic Surgery of Tokyo Medical University (Shinjuku-ku, Tokyo, Japan) led by Professor Kengo Yamamoto MD PhD recently completed a five million cycle (Mc) comparative hip simulator study examining the wear behavior of an advanced highly cross-linked and vitamin E stabilized polyethylene (E1® Zimmer-Biomet, Warsaw, IN, USA) against two different types of ceramic femoral heads -- MC2®silicon nitride (Amedica Corporation, Salt Lake City, UT, USA) and BIOLOX®delta (CeramTec, Plochingen, Germany). BIOLOX®delta is currently considered the "gold standard" for ceramic femoral head materials. While the polyethylene wear loss induced by both types of ceramic heads was extremely small (< 0.60 mg/Mc), mean wear associated with MC2®silicon nitride heads was approximately 15% lower than the BIOLOX®delta components.

Velano Vascular Receives Third FDA 510(k) Clearance for Innovative PIVO Needle-Free Blood Draw Technology

Mon, 27 Feb 2017 08:00:00 EST

Next generation design enables hospitals to deliver more compassionate, standardized, patient-centered blood draws

ALGAE DYNAMICS CORP Announces Research Agreement With University of Waterloo to Investigate Use of Cannabis Oil in the Context of Cancer

Fri, 24 Feb 2017 09:30:00 EST

TORONTO, ON--(Marketwired - Feb 24, 2017) - ALGAE DYNAMICS CORP (OTCQB: ADYNF) (the "Company"), a development stage company focused on the commercialization of its proprietary BioSilo® cultivation and extraction system for the growth of algae strains for use in the food and health supplement industry, today announced a research agreement with the University of Waterloo to perform fundamental research on cannabis oil and its constituents in the context of the development and treatment of cancers of the colorectum, pancreas, breast and prostate. The Sponsored Research Agreement is entitled "Studies on botanical oils from Algae Dynamics".

CloudHealth Genomics Presents their Unique Market Strategy and ImmuneSeq(TM) Panel for both Cancer and Non-Cancer Immunotherapies

Thu, 23 Feb 2017 14:06:03 EST

BOSTON, MA and SHANGHAI, CHINA--(Marketwired - Feb 23, 2017) - CloudHealth Genomics, Ltd., a leading genomics-based precision medicine solutions provider in China, presented data today on their unique business model, using open and disruptive innovation as a market strategy for precision medicine, wellness and longevity. In addition, data was presented as a by-product of the model, ImmuneSeq panel at the Cambridge Healthtech Institute's Third Annual Commercialization of Molecular Diagnostics, part of the 24th International Molecular Medicine Tri-Conference held in San Francisco, CA. ImmuneSeq is able to monitor immune responses, like T-cell activities for both cancer and non-cancer immunotherapies.

Somnia Announces Winner of Sixth Annual CRNA of the Year Award

Thu, 23 Feb 2017 10:00:00 EST

Randy Graybeal of Washington State-based PRMC Selected

Global Small Caps Initiates Coverage on Nutra Pharma

Wed, 22 Feb 2017 08:30:00 EST

CORAL SPRINGS, FL--(Marketwired - Feb 22, 2017) - Nutra Pharma Corporation (OTCQB: NPHC), a biotechnology company developing drugs for the treatment of Multiple Sclerosis and HIV that also markets Nyloxin® and Pet Pain-AwayT in the over-the-counter (OTC) pain management market, announced today that Global Small Caps has initiated coverage of the Company including operations and overall shareholder value.

Align Technology Announces Digital Implant Workflow for Its iTero(R) Scanners With Nobel Biocare(R) and Elos Medtech Scan Bodies

Wed, 22 Feb 2017 08:30:00 EST

Integration Streamlines Prosthetic Workflow for Dental Specialists

Southwest Cannabis Conference & Expo Returns to Texas for Largest Event Yet

Wed, 22 Feb 2017 06:00:00 EST

DALLAS, TX--(Marketwired - Feb 22, 2017) - The Southwest Cannabis Conference & Expo ( is returning to Texas for its second annual event. After setting new records at the last event in Phoenix -- where more than 150 exhibitors showcased their goods to over 6,800 attendees -- the SWCC Expo is looking to set new records in 2017.

Align Technology Announces New Global Brand Identity & Advertising Campaign for Invisalign(R) Clear Aligners

Tue, 21 Feb 2017 16:01:45 EST

"Made to Move" Campaign Harnesses Power of Invisalign Brand Across Both Consumer and Doctor Audiences Worldwide for First Time

SADA Systems and Children's Hospital Los Angeles Medical Group Honored as Recipients of the 2017 Microsoft Health Innovation Awards

Tue, 21 Feb 2017 10:06:45 EST

The cloud services and technology consulting firm teamed up with the largest pediatric multispecialty medical group in the United States to help fight infant blindness in Armenia

Medovex Corporation Provides Corporate Update

Tue, 21 Feb 2017 08:30:00 EST

Recent Completion of Final CE Mark Audit and Financing with Insider Participation Positions Company for 2017

Align Technology Announces Acquisition of Its Invisalign Distributor for the Europe, Middle East, and Africa Region

Tue, 21 Feb 2017 08:30:00 EST

SAN JOSE, CA--(Marketwired - February 21, 2017) - Align Technology, Inc. (NASDAQ: ALGN) today announced the acquisition of its distributor G.L. Dental Couture Limited, which is based in Dubai, United Arab Emirates and Nicosia, Cyprus. While the details of the acquisition remain confidential, this deal will give Align Technology direct access to customers and distribution partners across markets in Russia, Commonwealth of Independent States (CIS), Baltics, Turkey, Monaco, Israel, Cyprus, the Middle East and Africa. The deal is expected to be final on February 25, 2017 and at that time Align Technology will hold all rights to territories in the Europe, Middle East and Africa (EMEA) region, enabling the company to focus on driving accelerated growth across these markets. Align Technology will open its first office in the Middle East on February 26, 2017.

Department of Health and Human Services (HHS) New Rule Improves the Exchange of Medical Information that Protect the Privacy of People Receiving Substance Abuse Treatments

Tue, 21 Feb 2017 04:00:00 EST

SAN CLEMENTE, CA--(Marketwired - February 21, 2017) - Telehealthcare, Inc. ("") (OTC PINK: TLLT) The U.S. Department of Health and Human Services (HHS) published final rule changes to Confidentiality of Alcohol and Drug Abuse Patient Records regulations, (42 CFR Part 2) to be effective February 17, 2017.